Abstract
This review begins by attempting to recount some of the pioneering discoveries that first identified the presence of gangliosides in the nervous system, their structures and topography. This is presented as prelude to the current emphasis on physiological function, about which much has been learned but still remains to be elucidated. These areas include ganglioside roles in nervous system development including stem cell biology, membranes and organelles within neurons and glia, ion transport mechanisms, receptor modulation including neurotrophic factor receptors, and importantly the pathophysiological role of ganglioside aberrations in neurodegenerative disorders. This relates to their potential as therapeutic agents, especially in those conditions characterized by deficiency of one or more specific gangliosides. Finally we attempt to speculate on future directions ganglioside research is likely to take so as to capitalize on the impressive progress to date.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gabius H-J (ed) (2009) The sugar code. Fundamenals of glycosciences. Weinheim, Wiley-Blackwell
Klenk E (1942) Uber die Ganglioside, eine neue Gruppe von zuckerhaltigen Gehirnlipoiden. Hoppe Seylers Z Physiol Chem 273:76–86
Klenk E (1935) Uber die Natur der Phosphatide und anderer Lipoid des Gehirns und der Leber bei der Niemann-Pickschen Krankheit. Z Physiol Chem 235:24–36
Klenk E (1937) Die Fettstoffe des Gehirns bei amaurotischer Idiotie und Niemann-Pick’scher Krankheit. Ber Physiol 96:659–660
Varki A, Schauer R (2009) Sialic acids. In: Varki A et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Yamakawa T, Suzuki S (1951) The chemistry of the lipids of posthemolytic residue or stroma of erythrocytes. I Concerning the ether-insoluble lipids of lyophilized horse blood stroma. J Biochem 38:199–212
Kawano Y, Higuchi R, Komori T (1990) Isolation and structure of five new gangliosides. Liebig’s Ann Chem 1990:43–50
Kuhn R, Wiegandt H (1963) Die Konstitutionder Ganglio-N-tetraose und des gangliosids GI. Chem Ber 96:866–880
Chester MA (1998) IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids—recommendations 1997. Eur J Biochem 257:293–298
Svennerholm L (1963) Chromatographic separation of human bran gangliosides. J Neurochem 10:613–623
Kuhn R, Wiegandt H (1963) Die Konstitution der Ganglioside GII, GIII, und GIV. Z Naturforsch 18b:541–543
Klenk E, Gielen W (1963) Uber ein zweites hexosaminhaltiges Gangliosid aus Menschengehirn. Z Physiol Chem 330:218–226
Kuhn R, Wiegandt H (1964) Weitere Ganglioside aus Menschenhirn. Z Naturforsch 19b:256–257
Klenk E (1970) On the discovery and chemistry of neuraminic acid and gangliosides. Chem Phys Lipids 5:193–197
Klenk E, Liedtke U, Gielen W (1963) Das Gangliosid des Gehirns bei der intantilen amaurotischen idiote von Typ Tay-Sachs. Z Physiol Chem 334:186–192
Ledeen R, Salsman K (1965) Structure of the Tay-Sachs ganglioside. Biochemist 4:2225–2233
Yu RK, Yanagisawa M, Ariga T (2007) Glycosphingolipid sructures. In: Kamerling JP (ed) Comprehensive glycoscience. Elsevier, Oxford, pp 73–122
Hakomori S, Handa K, Iwabuchi K, Yasmamura S, Prinetti A (1998) New insights in glycosphingolipid function: “glycosignaling domain,” a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiol 8:xi–xix
Simons K, Sampaio JL (2011) Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol 3:a004697
Sonnino S, Mauri L, Chigorno V, Prinetti A (2007) Gangliosides as components of lipid membrane domains. Glycobiology 17:1R–13R
Furukawa K, Ohmi Y, Ohkawa Y, Tokuda N, Kondo Y, Tajima O, Furukawa K (2011) Regulatory mechanisms of nervous systems with glycoosphingolipids. Neurochem Res 36:1578–1586
Ohmi Y, Ohkawa Y, Yamauchi Y, Tajima O, Furukawa K, Furukawa K (2012) Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues. Neurochem Res 37:1185–1191
Nishio M, Fukumoto S, Furukawa K, Ichimura A, Miyazaki H, Kusunoki S, Urano T, Furukawa K (2004) Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J Biol Chem 279:33368–33378
Aureli M, Mauri L, Grazia Ciampa M, Prinetti A, Toffano G, Secchieri C, Sonnino S (2016) GM1 ganglioside: past studies and future potential. Mol Neurobiol 53:1824–1842
Ishizuka I, Wiegandt H (1972) An isomer of trisialoganglioside and the structure of tetra- and pentasialogangliosides from fish brain. Biochim Biophys Acta 260:279–289
Yu RK, Ando S (1980) Structure of some new complex gangliosides of fish brain. Adv Exp Med Biol 125:33–45
Irie F, Kurono S, Li Y-T, Seyama Y, Hirabayashi Y (1996) Isolation of three novel cholinergic neuron-specific gangliosides from bovine brain and their inn vitro syntheses. Glycoconj J 13:177–186
Svennerholm L, Bostrom K, Fredman P, Jungbjer B, Lekman A, Mansson JE, Rynmark BM (1994) Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta 1214:115–123
Yu RK, Ledeen R (1970) Gas-liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species. J Lipid Res 11:506–516
Miyagi T, Yamaguchi K (2012) Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 22:880–896
Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, Miyagi T (2002) A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 277:26252–26259
Ledeen R, Wu G (2015) The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci 40:407–418
Riboni L, Sonnino S, Acquotti D, Malesci A, Ghidoni R, Egge H et al (1986) Natural occurrence of ganglioside lactones. Isolation and characterization of GD1b inner ester from adult human brain. J Biol Chem 261:8514–8519
Li YT, Maskos K, Chou CW, Cole RB, Li SC (2003) Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain. J Biol Chem 278:35286–35291
Carter HE, Glick FJ, Norris WP, Phillips GE (1947) Biochemistry of sphingolipids. III. Structure of sphingosine. J Biol Chem 170:285–294
Sonnino S, Chigorno V (2000) Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim Biophys Acta 1469(2):63–77
Merrill AH Jr (2011) Sphingolipid and glycosphingoliipid metabolic pathways in the era of sphingolipidomics. Chem Rev 111:6387–6422
Martinez Z, Zhu M, Han S, Fink AL (2007) GM1 specifically interacts with α-synuclein and inhibits fibrillation. Biochemist 46:1868–1877
Bartels T, Kim NC, Luth ES, Selkoe DJ (2014) N-alpha-acetylation of alpha-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation. PLoS One 9:e103727
Fantini J (2007) Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. Curr Med Chem 14:2911–2917
Fantini J, Yahi N, Garmy N (2013) Cholesterol accelerates the binding of Alzheimer’s β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front Physiol 4(120). https://doi.org/10.3389/fphys.2013.00120
Fantini J, Yahi N (2011) Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. J Mol Biol 408:654–669
Hadaczek P, Wu G, Sharma N, Ciesielska A, Bankiewicz K, Davidow AL et al (2015) GDNF signaling implemented by GM1 ganglioside; failure in Parkinson’s disease and GM1-deficient murine model. Exp Neurol 263:177–189
Wu G, Lu Z-H, Wei TJ, Howells RD, Christoffers K, Ledeen RW (1998) The role of GM1 ganglioside in regulating excitatory opioid effects. Ann N Y Acad Sci 845:126–138
Wu G, Lu Z-H, Andre S, Gabius H-J, Ledeen RW (2016) Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca influx. J Neurochem 136:550–563
Lopez PH, Schnaar RL (2009) Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol 19:549–557
Manev H, Favaron M, Vicini S, Guidotti A, Costa E (1990) Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids. J Pharmacol Exp Ther 252:419–527
Wu G, Lu Z-H, Wang J, Wang Y, Xie X, Meyenhofer MF, Ledeen RW (2005) Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA20, a membrane-permeant analog of GM1. J Neurosci 25:11014–11022
Wu G, Lu Z-H, Kulkarni N, Ledeen RW (2012) Deficiency of ganglioside GM1 correlates with Parkinson’s disease in mice and humans. J Neurosci Res 90:1997–2008
Manna M, Javanainen M, Monne HM-S, Gabius H-J, Rog T, Vattulainen I (2017) Long-chain GM1 gangliosides alter transmembrane domain registration through interdigitation. Biochim Biophys Acta Biomembr 1859:870–878
Yu RK, Macala LJ, Taki T, Weinfeld HM, Yu FS (1988) Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem 50:1825–1829
Ngamukote S, Yanagisawa M, Ariga T, Ando S, Yu RK (2007) Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem 103:2327–2341
Tsai Y-T, Yu RK (2014) Epigenetic activation of mouse ganglioside synthase genes: implications for neurogenesis. J Neurochem 128:101–110
Tsai Y-T, Itokazu Y, Yu RK (2016) GM1 ganglioside is involved in epigenetic activation loci of neuronal cells. Neurochem Res 41:107–115
Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius H-J (1998) Galectin-1 is a major receptor for ganglioside GM1, a product of the growth controlling activity of a cell surface ganglioside sialidase on human neuroblastoma cells in culture. J Biol Chem 273:11205–11211
Purpura DP, Suzuki K (1976) Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res 116:1–21
Walkley SU, Wurzelmann S, Purpura DP (1981) Ultrastructure of neuritis and meganeurites of cortical pyramidal neurons in feline gangliosidosis as revealed by the combined Golgi-EM technique. Brain Res 211:393–398
Roisen FJ, Bartfeld H, Nagele R, Yorke G (1981) Ganglioside stimulation of axonal sprouting in vitro. Science 214:577–578
Facci L, Leon A, Toffano G, Sonnino S, Ghidoni R, Tettamanti G (1984) Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem 42:299–305
Byrne MC, Ledeen RW, Roisen FJ, Yorke G, Sclafani JR (1983) Ganglioside-induced neuritogenesis: verification that gangliosides are the active agents, and comparison of molecular species. J Neurochem 41(5):1214–1222
Cannella MS, Acher AJ, Ledeen RW (1998) Stimulation of neurite outgrowth in vitro by a glycerol-gangliioside. Int J Dev Neurosci 6:319–326
Wu G, Fang Y, Lu Z-H, Ledeen RW (1998) Induction of axon-like and dendrite-like processes in neuroblastoma cells. J Neurocytol 27:1–14
Yu RK, Suzuki Y, Yanagisawa M (2010) Membrane glycolipids in stem cells. FEBS Lett 584:1694–1699
Yanagisawa M (2011) Stem cell glycolipids. Neurochem Res 36:1623–1635
Wang J, Yu RK (2013) Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Nat Acad Sci 110:19137–19142
Wang J, Cheng A, Wakade C, Yu RK (2014) Ganglioside GD3 is required for neurogenesis and long-term maintenance of neural stem cells in the postnatal mouse brain. J Neurosci 34:13790–13800
Suzuki K (1965) The pattern of mammalian brain gangliosides – III. J Neurochem 12:969–979
Schwarz A, Futerman AH (1996) The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim Biophys Acta 1286:247–267
Schengrund C-L, Ringler NJ (1989) Binding of Vibrio cholera toxin and the heat labile enterotoxin of Escherichia coli to GM1 and derivatives of GM1. J Biol Chem 264:13233–13237
Vajn K, Viljetic B, Degmecic I, Schnaar RL, Heffer M (2013) Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS One 8:e75720
Colsch B, Jackson SN, Dutta S, Woods AS (2011) Molecular microscopy of brain gangliosides: illustrating their distribution in hippocampal cell layers. ACS Chem Neurosci 2:213–222
Schengrund C-L, Repman MA (1977) Cell culture of sixteen-day-old rat embryo cerebra and associated changes in ganglioside pattern. J Neurochem 29:923–927
Yavin E, Yavin Z (1979) Ganglioside profiles during neural tissue development. Dev Neurosci 2:25–37
Dreyfus H, Louis JC, Harth S, Mandel P (1980) Gangliosides in cultured neurons. Neuroscience 5:1647–1655
Sbaschnig-Agler M, Dreyfus H, Norton WT, Sensenbrenner M, Farooq M, Byrne MC, Ledeen RW (1988) Gangliosides of cultured astroglia. Brain Res 461:98–106
Asou H, Brunngraber EG (1983) Absence of ganglioside GM1 in astroglial cells from 21-day old rat brain: immunohistochemical, histochemical, and biochemical studies. Nerochem Res 8:1045–1057
Abe T, Norton WT (1974) The characterization of sphingolipids from neurons and astroglia of immature rat brain. J Neurochem 23:1025–1036
Norton WT, Abe T, Poduslo SE, DeVries GH (1975) The lipid composition of isolated brain cells and axons. J Neurosci Res 1:57–75
Hamburger A, Svennerholm L (1971) Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem 18:1821–1829
Robert J, Freysz L, Sensenbrenner M, Mandel P, Rebel G (1975) Gangliiosides of glial cells: a comparative study of normal astroblasts in tissue culture and glial cells isolated on sucrose-ficoll gradients. FEBS Lett 50:144–146
Byrne MC, Farooq M, Sbaschnig-Agler M, Norton WT, Ledeen RW (1988) Ganglioside content of astroglia and neurons isolated from maturing rat brain: consideration of the source of astroglial gangliosides. Brain Res 461:87–97
Gammon CM, Vaswani KK, Ledeen RW (1987) Isolation of two glycolipid transfer proteins from bovine brain: reactivity toward gangliosides and neutral glycosphingolipids. Biochemist 26:6239–6243
Seyfried TN, Yu RK, Miyazawa N (1982) Differential cellular enrichment of gangliosides in the mouse cerebellum: analysis using neurological mutants. J Neurochem 38:551–559
Giuliani A, Calappi E, Borroni E, Whittaker VP, Sonnino S, Tettamanti G (1990) Further studies on the gangliosidic nature of the cholinergic-specific antigen, Chol-1. Arch Biochem Biophys 280:211–216
Ando S, Hirabayashi Y, Kon K, Inagaki F, Tate S, Whittaker VP (1992) A trisialoganglioside containing a sialyl α2-6 N-acetylgalactosamine residue is a cholinergic specific antigen, Chol1-1α. J Biochem 111:287–290
Hirabayashi Y, Nakao T, Irie F, Whittaker VP, Kon K, Ando S (1992) Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain. J Biol Chem 267:12973–12978
Hirabayashi Y, Hyogo A, Nakao T, Tsuchiya K, Suzuki Y, Matsumoto M, Kon K, Ando S (1990) Isolation and characterization of extremely minor gangliosides, GM1b and GD1α, in adult bovine brains as developmentally regulated antigens. J Biol Chem 265:8144–8151
Ando S, Tanaka Y, Kobayashi S, Fukui F, Iwamoto M, Waki H, Tai T, Hirabayashi Y (2004) Synaptic function of cholinergic-specific Chol-1alpha ganglioside. Neurochem Res 29:857–867
Suzuki K, Poduslo SE, Norton WT (1967) Gangliosides in the myelin fraction of developing rats. Biochim Biophys Acta 144:375–381
Ledeen RW, Yu RK, Eng LF (1973) Gangliiosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J Neurochem 21:829–839
Cochran FB Jr, Yu RK, Ledeen RW (1982) Myelin gangliosides in vertebrates. J Neurochem 39:773–779
Yu RK, Iqbal K (1979) Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons. J Neurochem 32:293–300
Yu RK, Macala LJ, Farooq M, Sbaschnig-Agler NWT, Ledeen RW (1989) Ganglioside and lipid composition of bulk-isolated rat and bovine oligodendroglia. J Neurosci Res 23:136–141
Littlemore LAT, Ledeen RW (1979) N.M.R. studies of myelin basic protein. III. Interactions of the protein with lipid micelles by 1H and 31P N.M.R. Aust J Chem 32:2631–2636
Mullin BR, Decandis FX, Montanaro AJ, Reid JD (1981) Myelin basic protein interacts with the myelin-specific ganglioside GM4. Brain Res 222:218–221
Andersson LM, Fredman P, Lekman A, Rosengren L, Gisslen M (1998) Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res Hum Retrovir 14:1065–1969
Simon BM, Malisan F, Testi R, Nicotera P, Leist M (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9:758–767
Ogawa-Goto K, Abe T (1998) Gangliosides and glycosophingolipids of peripheral nervous system myelins—a minireview. Neurochem Res 23:305–310
Ohsawa T (1990) Rat dorsal root ganglion gangliosides during early development until senescence. Mech Aging Dev 53:259–266
Fong JW, Ledeen RW, Kundu SK, Brostoff SW (1976) Gangliosides of peripheral nerve myelin. J Neurochem 26:157–162
Avrova NF, Chenykaeva EY, Obukhova EL (1973) Ganglioside composition and content of rat-brain subcellular fractions. J Neurochem 20:997–1004
Breckenridge WC, Gombos G, Morgan IG (1972) The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim Biophys Acta 266:695–707
Lapetina EG, Soto EF, De Robertis E (1968) Lipids and proteolipids in isolated subcellular membranes of rat brain cortex. J Neurochem 15:437–445
Ledeen RW (1978) Ganglioside structures and distribution: are they localized at the nerve ending? J Supramol Struct 8:1–17
Skrivanek JA, Ledeen RW, Margolis RU, Margolis RK (1982) Gangliosides associated with microsomal subfractions of brain: comparison with synaptic plasma membranes. J Neurobiol 13:95–106
Hansson HA, Holmgren J, Svennerholm L (1977) Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci U S A 74:3782–3786
Devries GH, Zmachinski CJ (1980) The lipid composition of rat CNS axolemma-enriched fractions. J Neurochem 34:424–430
Forman DS, Ledeen RW (1972) Axonal transport of gangliosides in the goldfish optic nerve. Science 177:630–633
Aquino DA, Bisby MA, Ledeen RW (1987) Bidirectional transport of gangliosides, glycoproteins, and neutral glycosphingoliipids in the sensory neurons of rat sciatic nerve. Neuroscience 20:1023–1029
Ledeen RW, Diebler MF, Wu G, Lu ZH, Varoqui H (1993) Ganglioside composition of subcellular fractions, including pre- and postsynaptic membranes, from Torpedo electric organ. Neurochem Res 18:1151–1155
Sbaschnig-Agler M, Pfenninger KH, Ledeen RW (1988) Gangliosides and other lipids of the growth cone membrane. J Neurochem 51:212–220
Breckenridge WC, Morgan IG, Zanetta JP, Vincendon G (1973) Adult rat brain synaptic vesicles II. Lipid composition. Biochim Biophys Acta 320:681–686
Ledeen RW, Parsons SM, Diebler MF, Sbaschnig-Agler M, Lazereg S (1988) Ganglioside composition of synaptic vesicles from Torpedo electric organ. J Neurochem 51:1465–1469
Margolis RU, Ledeen RW, Sbaschnig-Agler M, Byrne MC, Kline RL, Douglas II, Margolis RK (1987) Complex carbohydrate composition of large dense-cored vesicles from sympathetic nerve. J Neurochem 49:1839–1844
Geisler D, Martinek A, Margolis RU, Margolis RK, Skrivanek JA, Ledeen R, Konig P, Winkler H (1977) Composition and biogenesis of complex carbohydrates of ox adrenal chromaffin granules. Neuroscience 2:685–693
Saito M, Sugiyama K (2002) Characterization of nuclear gangliosides in rat brain: concentration, composition, and developmental changes. Arch Biochem Biophys 398:153–159
Wu G, Lu Z-H, Ledeen RW (1995) Induced and spontaneous neritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. J Neurosci 15:3739–3746
Kiebish MA, Han X, Cheng H, Lunceford A, Clarke CF, Moon H et al (2008) Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem 106:299–312
Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P et al (2000) GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J 14:2047–2054
Wang J, Wu G, Miyagi T, Lu Z-H, Ledeen RW (2009) Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a. J Neurochem 111:547–554
Ravichandra B, Joshi PG (1999) Regulation of transmembrane signaling by ganglioside GM1: interaction of anti-GM1 with neuro2a cells. J Neurochem 73:557–567
Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J et al (2009) GM1-ganglioside accumulation at the mitochondria-associated ER membrane links ER stress to Ca-dependent mitochondrial apoptosis. Mol Cell 36:500–511
Nowycky MC, Wu G, Ledeen RW (2014) Glycobiology of ion transport in the nervous system. In: Yu RK, Schengrund C-L (eds) Glycobiology of the Nervous System. Springer, New York, pp 321–342
Leon A, Facci L, Toffano G, Sonnino S, Tettamanti G (1981) Activation of (Na+, K+)-ATPase by nanomolar concentations of GM1 ganglioside. J Nerochem 37:350–357
Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K et al (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956–3967
Qiao GF, Cheng ZF, Huo R, Sui XH, Lu YJ, Li BY (2008) GM1 ganglioside contributes to retain the neuronal conduction and neuronal excitability in visceral and baroreceptor afferents. J Neurochem 106:1637–1645
Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K et al (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55:746–757
de Erausquin GA, Manev H, Guidotti A, Costa E, Brooker G (1990) Gangliosides normalize distorted single-cell intracellular free Ca dynamics after toxic doses of glutamate in cerebellar granule cells. Proc Natl Acad Sci U S A 87:8017–8021
Wu G, Xie X, Lu Z-H, Ledeen RW (2001) Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium. Proc Natl Acad Sci U S A 98:307–312
Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B et al (2000) Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J 349(1):343–351
Wu G, Ledeen RW (1991) Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: putative role of GM1 ganglioside in differentiation. J Neurochem 56:95–104
Fang Y, Wu G, Xie X, Lu Z-H, Ledeen RW (2000) Endogenous GM1 gangliioside of the plasma membrane promotes neuritogenesis by two mechanisms. Neurochem Res 25:931–940
Rodriguez JA, Piddini E, Hasegawa T, Miyagi T, Dotti CG (2001) Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. J Neurosci 21:8387–8395
Kappagantula S, Andrews MR, Cheah M, Abad-Rodriguez J, Dotti CG, Fawcett JW (2014) Neu3 sialidase-mediated ganglioside conversion is necessary for axon regeneration and is blocked in CNS axons. J Neurosci 34:2477–2492
Wu G, Lu Z-H, Nakamura K, Spray DC, Ledeen RW (1996) Trophic effect of cholera toxin B subunit in cultured cerebellar granule neurons: modulation of intracellular calcium by GM1 ganglioside. J Neurosci Res 44:243–254
Milani D, Minozzi MC, Petrelli L, Guidolin D, Skaper SD, Spoerri PE (1992) Interaction of ganglioside GM1 with the B subunit of cholera toxin modulates intracellular free calcium in sensory neurons. J Neurosci Res 33:466–475
Wu G, Lu ZH, Obukhov AG, Nowycky MC, Ledeen RW (2007) Induction of calcium influx through TRPC5 channels by cross-linking of GM1 ganglioside associated with alpha5beta1 integrin initiates neurite outgrowth. J Neurosci 27:7447–7458
Wang J, Lu Z-H, Gabius H-J, Rohowsky-Kochan C, Ledeen RW, Wu G (2009) Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182:4036–4045
Ledeen RW, Wu G, Andre S, Bleich D, Huet G, Kaltner H et al (2012) Beyond glycoproteins as galectin-counterreceptors: tumor-effector cell growth control via ganglioside GM1. Ann N Y Acad Sci 1253:206–221
Xie X, Wu G, Lu Z-H, Ledeen RW (2002) Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J Neurochem 81:1185–1195
Burette A, Rockwood JM, Strehler EE, Weinberg RJ (2003) Isoform-specific distribution of the plasma membrane Ca2+ ATPase in the rat brain. J Comp Neurol 467:464–476
Zhao Y, Fan X, Yang F, Zhang X (2004) Gangliosides modulate the activity of the plasma membrane Ca(2+)-ATPase from porcine brain synaptosomes. Arch Biochem Biophys 427:204–212
Jiang L, Bechtel MD, Bean JL, Winefield R, Williams TD, Zaidi A et al (2014) Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase. Biochim Biophys Acta Biomembr 1838:1255–1265
Tessitore A, del P Martin M, Sano R, Ma Y, Mann L, Ingrassia A et al (2004) GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 15:753–766
d’Azzo A, Tessitore A, Sano R (2006) Gangliosides as apoptotic signals in ER stress response. Cell Death Diff 13:404–414
Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt FM, Futerman AH (2003) Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with butyldeoxynojirimycin. J Biol Chem 278(32):29496–29501
Wang Y, Tsui Z, Yang F (1999) Antagonistic effect of ganglioside GM1 and GM3 on the activity and conformation of sarcoplasmic reticulum Ca2+-ATPase. FEBS Lett 457:144–148
Wu G, Lu Z-H, Xie X, Ledeen RW (2004) Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20. Glycoconj J 21:305–313
Wu G, Xie X, Lu Z-H, Ledeen RW (2009) Sodium-calcium exchanger complexed with GM1 ganglioside in the nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulum. Proc Natl Acad Sci U S A 106:10829–10834
Galva C, Artigas P, Gatto C (2012) Nuclear Na+/K+-ATPase plays an active role in nucleoplasmic Ca2+ homeostasis. J Cell Sci 125:6137–6147
Xie X, Wu G, Lu Z-H, Rohowsky-Kochan C, Ledeen RW (2004) Presence of sodium-calcium exchanger/GM1 complex in the nuclear envelope of non-neural cells: nature of the exchanger-GM1 interaction. Neurochem Res 29:2135–2146
Xie X, Wu G, Ledeen RW (2004) C6 cells express a sodium-calcium exchanger/GM1 complex in the nuclear enveklope but have no exchanger in the plasma membrane: comparison to astrocytes. J Neurosci Res 76:363–357
Kaucic K, Liu Y, Ladisch S (2006) Modulation of growth factor signaling by gangliosides: positive or negative? Methods Enzymol 417:168–185
Rusnati M, Tanghetti E, Urbinati C, Tulipano G, Marchesini S, Ziche M, Presta M (1999) Interaction of fibroblast growth factor-2 (FGF-2) with free gsangliosides: biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell 10:313–327
Rusnati M, Urbinati C, Tanghetti E, Dell’Era P, Lortat-Jacob H, Presta M (2002) Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc Natl Acad Sci U S A 99:4367–4372
Boldin SA, Futerman ASH (2000) Up-reguloation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post-translational modification of glucosylceramide synthase. J Biol Chem 275:9905–9909
Nojiri H, Stroud M, Hakomori S-I (1991) A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity. J Biol Chem 266:4531–4537
Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S et al (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A 104:13678–13683
Schengrund C-L (2015) Gangliosides: glycosphingolipids essential for normal neural development and function. Trends Biochem Sci 40:397–406
Shen KF, Crain SM (1989) Dual modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res 491:227–242
Jin W, Lee NM, Loh HH, Thayer SA (1992) Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharm 42:1083–1089
Shen KF, Crain SM (1990) Cholera toxin B-subunit blocks opioid excitatory effects on sensory neuron action potentials indicating the GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res 531:1–7
Wu G, Lu Z-H, Ledeen RW (1997) Interaction of δ-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Mol Brain Res 44:341–346
Saito M, Frielle T, Benovic JL, Ledeen RW (1995) Modulation by GM1 ganglioside of β1-adrenergic receptor-induced cyclic AMP formation in Sf9 cells. Biochim Biophys Acta 1267:1–5
Wu G, Lu Z-H, Ledeen RW (1996) GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in Neuro-2A cells. Glycoconj J 13:235–239
Lundius EG, Stroth N, Vukojevic V, Terenius L, Svenningsson P (2012) Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line. J Neurochem 124:410–417
Lundius EG, Vukojevic V, Hertz E, Stroth N, Cederlund A, Hiraiwa M et al (2014) GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability. J Biol Chem 289:4660–4673
Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci U S A 92:5087–5091
Rabin SJ, Mocchetti I (1995) GM1 ganglioside activates the high-affinity nerve growth factor receptor TrkA. J Neurochem 65:347–354
Pitto M, Mutoh T, Kuriyama M, Ferraretto A, Palestini P, Masserini M (1998) Influence of endogenous GM1 ganglioside on TrkB activity in cultured neurons. FEBS Lett 439:93–96
Mutoh T, Hamano T, Tokuda A, Kuriyama M (2000) Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells). Glycoconj J 17:233–237
Mutoh T, Hamano T, Yano S, Koga H, Yamamoto H, Furukawa K, Ledeen RW (2002) Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem Res 27:801–806
Volk BW, Aronson SM (eds) (1972) Sphingolipids, sphingolipidoses and allied disorders. Advances in experimental medicine and biology, vol 19. Plenum, London
Kolter T (2012) Ganglioside Biochemistry. ISRN Biochem 2012(506160):1–36
Ceccarelli B, Aporti F, Finesso M (1976) Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation. Adv Exp Med Biol 71:275–293
Ledeen RW, Hogan EL, Tettamanti G, Yates AJ, Yu RK (eds) (1988) New trends in ganglioside research. Neurochemical and neuroregenerative aspects. Fidia research series, vol 14. Liviana Press, Padova
Saito M, Saito M, Berg MJ, Guidotti A, Marks N (1999) Gangliosides attenuate ethanol-induced apoptosis in rat cerebellar granule neurons. Neurochem Res 24:1107–1115
Kidd SK, Mettil W, Anderson DW, Schneider JS (2012) Ganglioside regulation in human substantia nigra and its relation to Parkinson’s disease. Program no. 754.16. 2012 Neuroscience meeting planner. Society for Neuroscience, New Orleans. Online: 2012
Jellinger KA (2011) Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci 310:107–111
Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson’s disease: clinical features and detection strategies. Mov Disord 26:775–783
Halliday GM, Barker RA, Rowe DB (eds) (2011) Non-dopamine Lesions in Parkinson’s disease. Oxford University Press, Oxford
Toffano G, Savoini G, Moroni F, Lombardi G, Calza L, Agnati LF (1983) GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Brain Res 261:163–166
Hadjiconstantinou M, Rossetti ZL, Paxton RC, Neff NH (1986) Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacology 25:1075–1077
Schneider JS, Yuwiler A (1989) GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. Exp Neurol 105:177–183
Tilson HA, Harry GJ, Nanry K, Hudson PM, Hong JS (1988) Ganglioside interactions with the dopaminergic system of rats. J Neurosci Res 19:88–93
Schneider JS, Pope A, Simpson K, Taggart J, Smith MG, DiStefano L (1992) Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Science 256:843–846
Herrero MT, Perez-Otano I, Oset C, Kastner A, Hirsch EC, Agid Y et al (1993) GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56:965–972
Schneider JS, DiStefano L (1995) Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion. Neuropharmacology 34:489–493
Schneider JS, Sendek S, Daskalakis C, Cambi F (2010) GM1 ganglioside in Parkinson’s disease: results of a five-year open study. J Neurol Sci 292:45–51
Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W (2013) A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson’s disease patients. J Neurol Sci 324:140–148
Wu G, Lu Z-H, Kulkarni N, Amin R, Ledeen RW (2011) Mice lacking major brain gangliosides develop parkinsonism. Neurochem Res 36:1706–1714
Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, Lopez-Barneo J (2008) Absollute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci 11:755–761
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840
Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72
Braak H, Del Tredici K, Rub U, de Vos RAI, Steur ENHJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Schneider JS (2014) Gangliosides and glycolipids in neurodegenerative disorders. In: Yu RK, Schengrund C-L (eds) Glycobiology of the nervous system. Advances in neurobiology, vol 9. Springer, New York, pp 449–464
Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo S-H et al (2015) Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutation. Brain 138:2648–2658
Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH (2011) Lysosomal storage disorders and Parkinson’s disease: Gaucher disease and beyond. Mov Disord 26:1593–1604
Roze E, Paschke E, Lopez N, Eck T, Yoshida K, Maurel-Olivier A et al (2005) Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 20:1366–1369
Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2:1403
Lulita MF, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Alzheimer’s disease and Down syndrome. Trends Pharm Sci 35:338–348
Svennerholm L, Gottfries C-G (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early onset (type I) and demyelination in late-onset form (type II). J Neurochem 62:1039–1047
Brooksbank BW, McGovern J (1989) Gangliosides in the brain in adult Down’s syndrome and Alzheimer’s disease. Mol Chem Neuropathol 11:143–156
Crino PB, Ullman MD, Vogt BA, Bird ED, Volicer L (1989) Brain gangliosides in dementia of the Alzheimer type. Arch Neurol 46:398–401
Valdes-Gonzalez T, Goto-Inoue N, Hirano W, Ishiyama H, Hayasaka T, Setou M, Taki T (2011) New approach for glyco-and lipidomics – molecular scanning of human brain gangliosides by TLC-Blot and MALDI-QIT-TOF MS. J Neurochem 116:678–683
Kracun I, Rosner H, Drnovsek V, Heffer-Lauc M, Cosovic C, Lauc G (1991) Human brain gangliosides in development, aging and disease. Int J Dev Biol 35:289–295
Ariga T, McDonald MP, Yu RK (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease – a review. J Lipid Res 49:1157–1175
Hayashi H, Kimura N, Yamaguchi H, Hasegawa K, Yokoseki T, Shibata M et al (2004) A seed for Alzheimer amyloid in the brain. J Neurosci 24:4894–4902
Yanagisawa K (2007) Role of gangliosides in Alzheimer’s disease. Biochim Biophys Acta 1768:1943–1951
Yanagisawa M, Ariga T, Yu RK (2010) Cytotoxic effects of GM1 ganglioside and amyloid β-peptide on mouse embryonic neural stem cells. ASN Neuro 2:e00029
Svennerholm L, Brane G, Karlsson I, Lekman A, Ramstrom I, Wikkelso C (2002) Alzheimer disease – effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr Cogn Disord 14:128–136
Kreutz F, Frozza RL, Breier AC, de Oliveira VA, Horn AP, Pettenuzzo LF et al (2011) Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action. Neurochem Int 59:648–655
Ariga T, Yu RK (1999) GM1 inhibits amyloid beta-protein-induced cytokine release. Neurochem Res 24:219–226
Sokolova TV, Zakharova IO, Furaev VV, Rychkova MP, Avrova NF (2007) Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen perkoxide and amyloid β-peptide in PC12 cells. Neurochem Res 32:1302–1313
Bernardo A, Harrison FE, McCord M, Zhao J, Bruchey A, Davies SS et al (2009) Elimination of GD3 synthase improves memory and reduces amyloid-β beta plaque load in transgenic mice. Neurobiol Aging 30:1777–1791
Copani A, Melchiorri D, Caricasole A, Martini F, Sale P, Carnevale R et al (2002) β-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J Neurosci 22:3963–3968
Galpern WSR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59:449–458
Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR, Sutcliffe JG et al (2007) Glycolipid and ganglioside metabolism imbalances in Huntington’s disease. Neurobiol Dis 27:265–277
Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, Sipione S (2010) Impaired ganglioside metabolism in Huntington’s disease and neuroprotective role of GM1. J Neurosci 30:4072–4080
Di Pardo A, Maglione V, Alpaugh M, Horkey M, Atwal RS, Sassone J et al (2012) Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci U S A 109:3528–3533
Boukhris A, Schule R, Loureiro JL, Lourenco CM, Mundwiller E, Gonzalwz MA et al (2013) Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Gen 93:118–123
Chiavegatto S, Sun J, Nelson RJ, Schnaar RL (2000) A functional role for complex gangliosides: motor deficits GM2/GD2 synthase knockout mice. Exp Neurol 166:227–234
Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DCA, Reinkensmeier G (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Gen 36:1225–1229
Yoshikawa M, Go S, Takasaki K, Kakazu Y, Ohashi M, Nagafuku M et al (2009) Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc Natl Acad Sci U S A 106:9483–9488
Niimi K, Nishioka C, Miyamoto T, Takahashi E, Miyoshi I, Itakura C, Yamashita T (2011) Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice. Biochem Biophys Res Commun 406:524–528
Tell S (2012) Medical genetic research on the Amish: from genetic tourism to community health centers. Einstein J Biol Med 2012:18–24
Allende ML, Proia RL (2014) Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glyconj J 31:613–622
Itokazu Y, Tsai Y-T, Yu RK (2016) Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells. Glycoconj J. https://doi.org/10.1007/s10719–016–9719-6
Sampson TR, Debellus JW, Thron T, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167:1469–1480
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ledeen, R., Wu, G. (2018). Gangliosides of the Nervous System. In: Sonnino, S., Prinetti, A. (eds) Gangliosides. Methods in Molecular Biology, vol 1804. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8552-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8552-4_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8551-7
Online ISBN: 978-1-4939-8552-4
eBook Packages: Springer Protocols